{"id":"https://openalex.org/W2054520600","doi":"https://doi.org/10.1634/stemcells.2006-0638","title":"Chronic Myeloid Leukemia Blast Crisis Arises from Progenitors","display_name":"Chronic Myeloid Leukemia Blast Crisis Arises from Progenitors","publication_year":2007,"publication_date":"2007-01-11","ids":{"openalex":"https://openalex.org/W2054520600","doi":"https://doi.org/10.1634/stemcells.2006-0638","mag":"2054520600","pmid":"https://pubmed.ncbi.nlm.nih.gov/17218393"},"language":"en","primary_location":{"id":"doi:10.1634/stemcells.2006-0638","doi":"https://doi.org/10.1634/stemcells.2006-0638","is_oa":false,"landing_page_url":"https://doi.org/10.1634/stemcells.2006-0638","pdf_url":null,"source":{"id":"https://openalex.org/S65139510","display_name":"Stem Cells","issn_l":"1066-5099","issn":["1066-5099","1549-4918"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Stem Cells","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5091861581","display_name":"Franziska Michor A","orcid":"https://orcid.org/0000-0003-4869-8842","observed_orcids":["https://orcid.org/0000-0003-4869-8842","https://orcid.org/0009-0003-8552-7767"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Franziska Michor","raw_affiliation_strings":["Society of Fellows, Harvard University, Cambridge, Massachusetts, USA, and Dana Farber Cancer Institute, Boston, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Society of Fellows, Harvard University, Cambridge, Massachusetts, USA, and Dana Farber Cancer Institute, Boston, Massachusetts, USA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5091861581"],"corresponding_institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"],"apc_list":{"value":4477,"currency":"USD","value_usd":4477},"apc_paid":null,"fwci":4.0485,"has_fulltext":false,"cited_by_count":43,"citation_normalized_percentile":{"value":0.93767602,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"25","issue":"5","first_page":"1114","last_page":"1118"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11829","display_name":"Mathematical Biology Tumor Growth","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2611","display_name":"Modeling and Simulation"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-myeloid-leukemia","display_name":"chronic myeloid leukemia","score":0.9990000128746033},{"id":"https://openalex.org/keywords/blast-crisis","display_name":"blast crisis","score":0.9860000014305115},{"id":"https://openalex.org/keywords/leukemia-stem-cells","display_name":"leukemia stem cells","score":0.8820000290870667},{"id":"https://openalex.org/keywords/imatinib","display_name":"imatinib","score":0.7630000114440918},{"id":"https://openalex.org/keywords/disease-progression","display_name":"disease progression","score":0.7599999904632568},{"id":"https://openalex.org/keywords/mathematical-model","display_name":"mathematical model","score":0.7929999828338623},{"id":"https://openalex.org/keywords/bcr-abl","display_name":"BCR-ABL","score":0.7839999794960022},{"id":"https://openalex.org/keywords/accelerated-phase","display_name":"accelerated phase","score":0.8190000057220459},{"id":"https://openalex.org/keywords/cell-of-origin","display_name":"cell of origin","score":0.6700000166893005}],"concepts":[{"id":"https://openalex.org/C2777583451","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib","level":3,"score":0.744253396987915},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.7009939551353455},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.6637243032455444},{"id":"https://openalex.org/C201750760","wikidata":"https://www.wikidata.org/wiki/Q1896218","display_name":"Progenitor cell","level":3,"score":0.6311776638031006},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5924718379974365},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.588377833366394},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.525233268737793},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4898485839366913},{"id":"https://openalex.org/C3019892230","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib mesylate","level":4,"score":0.48862749338150024},{"id":"https://openalex.org/C111829193","wikidata":"https://www.wikidata.org/wiki/Q1108970","display_name":"Fusion gene","level":3,"score":0.4193163216114044},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.15782925486564636},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.11684960126876831}],"mesh":[{"descriptor_ui":"D000068877","descriptor_name":"Imatinib Mesylate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001549","descriptor_name":"Benzamides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001752","descriptor_name":"Blast Crisis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D001752","descriptor_name":"Blast Crisis","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014411","descriptor_name":"Neoplastic Stem Cells","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D015464","descriptor_name":"Leukemia, Myelogenous, Chronic, BCR-ABL Positive","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D015464","descriptor_name":"Leukemia, Myelogenous, Chronic, BCR-ABL Positive","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D018448","descriptor_name":"Models, Immunological","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1634/stemcells.2006-0638","doi":"https://doi.org/10.1634/stemcells.2006-0638","is_oa":false,"landing_page_url":"https://doi.org/10.1634/stemcells.2006-0638","pdf_url":null,"source":{"id":"https://openalex.org/S65139510","display_name":"Stem Cells","issn_l":"1066-5099","issn":["1066-5099","1549-4918"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Stem Cells","raw_type":"journal-article"},{"id":"pmid:17218393","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17218393","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Stem cells (Dayton, Ohio)","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":45,"referenced_works":["https://openalex.org/W19160273","https://openalex.org/W120597284","https://openalex.org/W287390018","https://openalex.org/W1490418776","https://openalex.org/W1510546584","https://openalex.org/W1835750525","https://openalex.org/W1980473329","https://openalex.org/W1987239635","https://openalex.org/W1994072538","https://openalex.org/W1995401053","https://openalex.org/W1998593414","https://openalex.org/W1999277101","https://openalex.org/W1999614615","https://openalex.org/W2006917576","https://openalex.org/W2012962381","https://openalex.org/W2017063794","https://openalex.org/W2018279800","https://openalex.org/W2028959752","https://openalex.org/W2040396943","https://openalex.org/W2047224624","https://openalex.org/W2058564254","https://openalex.org/W2070067474","https://openalex.org/W2071808385","https://openalex.org/W2074740152","https://openalex.org/W2076372887","https://openalex.org/W2079517811","https://openalex.org/W2082580993","https://openalex.org/W2083530483","https://openalex.org/W2090786449","https://openalex.org/W2098785293","https://openalex.org/W2102085111","https://openalex.org/W2108470021","https://openalex.org/W2110981938","https://openalex.org/W2118453722","https://openalex.org/W2124082414","https://openalex.org/W2127753323","https://openalex.org/W2138993111","https://openalex.org/W2142969636","https://openalex.org/W2149468947","https://openalex.org/W2154856176","https://openalex.org/W2263837564","https://openalex.org/W2412126852","https://openalex.org/W2491446616","https://openalex.org/W2581094758","https://openalex.org/W2590189866"],"related_works":["https://openalex.org/W2052617751","https://openalex.org/W2054144619","https://openalex.org/W1971725715","https://openalex.org/W2017779964","https://openalex.org/W2102983508","https://openalex.org/W2502061088","https://openalex.org/W2160396724","https://openalex.org/W7097015077","https://openalex.org/W4252623514","https://openalex.org/W1972035400"],"abstract_inverted_index":{"Chronic":[0],"myeloid":[1],"leukemia":[2],"(CML)":[3],"progresses":[4],"through":[5],"three":[6],"distinct":[7],"clinical":[8],"stages:":[9],"chronic":[10,46],"phase,":[11,13],"accelerated":[12,20],"and":[14,22,96,145],"blast":[15,23,56,72],"crisis.":[16],"The":[17,51],"progression":[18,113,139],"to":[19,74,99,151,170],"phase":[21,47],"crisis":[24,57,73],"is":[25,58,181],"driven":[26],"by":[27,126],"activation":[28],"of":[29,32,38,48,53,55,61,70,91,103,108,138,154,176,179,186],"oncogenes,":[30],"inactivation":[31],"tumor":[33],"suppressor":[34],"genes,":[35],"and/or":[36],"amplification":[37],"the":[39,45,49,101,106,112,136,184],"BCR-ABL":[40],"fusion":[41],"gene,":[42],"which":[43],"causes":[44],"disease.":[50],"cell":[52],"origin":[54],"a":[59,66],"subject":[60],"speculation.":[62],"Here,":[63],"I":[64,88],"develop":[65],"simple":[67],"mathematical":[68],"model":[69],"CML":[71,166],"investigate":[75],"whether":[76],"blasts":[77,123,167],"arise":[78,171],"from":[79,172],"leukemic":[80,86,127,156,163,173],"stem":[81,128,157],"cells":[82],"or":[83],"more":[84],"differentiated":[85],"cells.":[87,158],"use":[89],"data":[90],"patients":[92,141],"treated":[93,142],"with":[94,118,143],"imatinib":[95,144,149],"previous":[97,119,146],"agents":[98],"estimate":[100],"effects":[102],"therapy":[104],"on":[105],"rate":[107,114,137],"progression.":[109],"Imatinib":[110,159],"reduces":[111],"10-fold":[115],"as":[116],"compared":[117],"(ineffective)":[120],"therapies.":[121],"If":[122],"were":[124],"produced":[125],"cells,":[129],"there":[130],"would":[131],"be":[132,152],"no":[133],"difference":[134],"in":[135],"between":[140],"therapies,":[147],"because":[148],"seems":[150],"incapable":[153],"depleting":[155],"does,":[160],"however,":[161],"deplete":[162],"progenitors.":[164,174],"Therefore,":[165],"are":[168],"likely":[169],"Disclosure":[175],"potential":[177],"conflicts":[178],"interest":[180],"found":[182],"at":[183],"end":[185],"this":[187],"article.":[188]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":4}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}
